Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.14%53.070.9%$1380.41m
JNJJohnson & Johnson 1.26%179.210.7%$1369.61m
BMYBristol-Myers Squibb Co. 1.03%76.981.0%$1209.69m
MRKMerck & Co., Inc. 0.65%94.160.7%$1147.08m
ABBVAbbVie, Inc. -0.96%149.561.9%$1127.19m
LLYEli Lilly & Co. 1.42%303.091.1%$904.87m
AZNAstraZeneca Plc 0.64%66.641.0%$521.01m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.11%143.600.0%$463.57m
VERUVeru, Inc. -1.57%13.170.0%$313.66m
NVSNovartis AG 1.39%90.670.2%$254.71m
GSKGlaxoSmithKline Plc 0.72%44.840.2%$244.91m
HZNPHorizon Therapeutics Plc -1.85%88.685.4%$196.70m
NVONovo Nordisk A/S 0.19%107.950.1%$191.08m
SGENSeagen Inc. 0.53%140.385.7%$182.72m
VTRSViatris, Inc. -1.40%11.640.0%$163.88m

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.